Your browser doesn't support javascript.
Heterogeneous immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy.
Bowes, Cynthia L; Naranbhai, Vivek; St Denis, Kerri J; Lam, Evan C; Bertaux, Brittany; Keane, Florence K; Khandekar, Melin J; Balazs, Alejandro B; Iafrate, John A; Gainor, Justin F; Willers, Henning.
  • Bowes CL; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Naranbhai V; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • St Denis KJ; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
  • Lam EC; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
  • Bertaux B; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Keane FK; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Khandekar MJ; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA.
  • Balazs AB; Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA, USA.
  • Iafrate JA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.
  • Gainor JF; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Willers H; Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA. Electronic address: hwillers@mgh.harvard.edu.
Radiother Oncol ; 166: 88-91, 2022 01.
Article in English | MEDLINE | ID: covidwho-1537007
ABSTRACT
The immunogenicity of SARS-CoV-2 vaccines in cancer patients receiving radiotherapy is unknown. This prospective cohort study demonstrates that anti-SARS-CoV-2 spike antibody and neutralization titers are reduced in a subset of thoracic radiotherapy patients, possibly due to immunosuppressive conditions. Antibody testing may be useful to identify candidates for additional vaccine doses.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Radiother Oncol Year: 2022 Document Type: Article Affiliation country: J.radonc.2021.11.012

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Neoplasms Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Radiother Oncol Year: 2022 Document Type: Article Affiliation country: J.radonc.2021.11.012